CLEVELAND, OH
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION, founded in 1991, is a community nonprofit in the Medical Research sector that reported $5.2M in total revenue in fiscal year 2025.
THE PRIMARY TAX-EXEMPT PURPOSE OF THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION, A 501(C)(3) MEDICAL RESEARCH FOUNDATION ESTABLISHED IN ACCORDANCE WITH TITLE 38, SUBCHAPTER IV-RESEARCH AND EDUCATION CORPORATIONS, SECTIONS 7361-7368, IS TO SUPPORT BIOMEDICAL AND CLINICAL RESEARCH AS WELL AS TO PROVIDE HEALTH-RELATED EDUCATIONAL ACTIVITIES IN CONJUNCTION WITH THE LOUIS STOKES CLEVELAND DEPARTMENT OF VA MEDICAL CENTER (VAMC). RESEARCH SPONSORED BY THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION BENEFITS VETERANS TREATED AT THE LOUIS STOCKS CLEVELAND VAMC AND THE GENERAL PUBLIC BY ADVANCING KNOWLEDGE IN THE DIAGNOSIS AND TREATMENT OF DISEASE AND DISABILITY. EDUCATION PROGRAMS SUPPORTED BY THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION HELP DISSEMINATE THE RESULTS OF RESEARCH SO THEY MAY BE TRANSLATED TO CLINICAL PRACTICE, PROVIDE HOSPITAL STAFF WITH TRAINING IN THE LATEST TREATMENTS, AND HELP PATIENTS UNDERSTAND AND MANAGE THEIR MEDICAL CONDITIONS.
DR. HAMID CHARKHKAR, PHD- DOD "NEURALLY INTEGRATED LOWER LIMB PROSTHESIS FOR HOME AND COMMUNITY USE" THE OBJECTIVE OF THIS STUDY IS TO DEVELOP AND DEPLOY A FULLY IMPLANTABLE, SELF-CONTAINED LOWER...
DR. HAMID CHARKHKAR, PHD- DOD "NEURALLY INTEGRATED LOWER LIMB PROSTHESIS FOR HOME AND COMMUNITY USE" THE OBJECTIVE OF THIS STUDY IS TO DEVELOP AND DEPLOY A FULLY IMPLANTABLE, SELF-CONTAINED LOWER LIMB SENSORY NEUROPROSTHESIS THAT IS EASY-TO-USE IN THE COMMUNITY AND/OR ACTIVE-DUTY ENVIRONMENTS. DOING SO COULD PROVIDE WARFIGHTERS WITH LOWER LIMB LOSS THE ABILITY TO POTENTIALLY RETURN TO ACTIVE DUTY OR FACILITATE RESUMPTION OF A HEALTHY AND SOCIALLY ENGAGED LIFESTYLE. CONVENTIONAL PROSTHESES ARE NOT DESIGNED TO EFFECTIVELY INTERFACE WITH COMPROMISED SKELETAL, MUSCULAR, AND NERVOUS SYSTEMS FOLLOWING A LOWER LIMB AMPUTATION. ALTHOUGH NUMEROUS ADVANCED PROSTHESES HAVE BEEN DEVELOPED, NO COMMERCIALLY AVAILABLE DEVICE CAN PROVIDE A DIRECT NEURAL CONNECTION TO THE REMAINING NERVES IN THE RESIDUAL LIMB SO THAT SOMATOSENSORY FEEDBACK OF PROSTHETIC FOOT-FLOOR INTERACTIONS CAN BE UTILIZED. SENSORY RESTORATION APPROACHES USING A DIRECT NEURAL INTERFACE HAVE REPORTED POSITIVE EFFECTS, INCLUDING AN INCREASE IN WALKING SPEED, REDUCTION IN PHANTOM PAIN, AND LIGHTER WEIGHT PERCEPTION OF THE PROSTHESIS. HOWEVER, MOST TESTS WITH THESE SYSTEMS HAVE BEEN PERFORMED IN CONTROLLED LABORATORY ENVIRONMENTS, AND THEIR EFFECTS DURING ACTIVITIES OF DAILY LIVING ARE LARGELY UNKNOWN. PROBING SUCH EFFECTS REQUIRES EXAMINING THE LONG-TERM USE OF THESE PROSTHESES OUTSIDE THE LABORATORY WHILE USERS ENGAGE IN CHALLENGING PHYSICAL ACTIVITIES TYPICAL IN THEIR EVERYDAY LIVES. WE HYPOTHESIZE THAT PROLONGED USE OF THE NEUROPROSTHESIS AT HOME AND IN THE COMMUNITY WILL IMPROVE STANDARD STATIC AND DYNAMIC MEASURES OF BALANCE AND GAIT STABILITY REVEALED THROUGH QUANTITATIVE POSTUROGRAPHY AND GAIT ANALYSIS.
DR. RONALD TRIOLO, PHD-CRAIG H. NEILSEN FOUNDATION "THE NORTHEAST OHIO PARAROWING SOCIETY" GOAL OF THIS PROJECT IS TO ESTABLISH A NEW PARAROWING PROGRAM FOR INDIVIDUALS WITH SCI IN NORTHEASTERN OHIO...
DR. RONALD TRIOLO, PHD-CRAIG H. NEILSEN FOUNDATION "THE NORTHEAST OHIO PARAROWING SOCIETY" GOAL OF THIS PROJECT IS TO ESTABLISH A NEW PARAROWING PROGRAM FOR INDIVIDUALS WITH SCI IN NORTHEASTERN OHIO. PARAROWING PROGRAMS EXIST IN MANY PARTS OF THE US, BUT SUCH OPPORTUNITIES ARE UNAVAILABLE IN CLEVELAND OR ANYWHERE NORTH OF COLUMBUS FROM TOLEDO TO YOUNGSTOWN. THIS REPRESENTS A SIGNIFICANT BARRIER FOR INDIVIDUALS WITH SCI TO EXPERIENCE THE EXERCISE AND CAMARADERIE OF A DYNAMIC AND EXPANDING REGIONAL ROWING COMMUNITY, AND AN OBSTACLE TO ACCESSING OUR NATURAL RESOURCES AND ENJOYING OPPORTUNITIES FOR SOCIAL ENGAGEMENT. THE NORTHEAST OHIO PARAROWING SOCIETY (NEOPS) WILL REMOVE THESE IMPEDIMENTS TO PARTICIPATION IN THE LOCAL ROWING COMMUNITY AND CREATE A NEW OUTLET TO ACTIVELY TAKE ADVANTAGE OF AN OTHERWISE UNAVAILABLE OPPORTUNITY. OUR OBJECTIVES ARE TO 1) ESTABLISH THE PROCEDURES NECESSARY TO INTRODUCE INDIVIDUALS WITH SCI TO SCULLING IN ADAPTED SHELLS WITH PROPER TECHNIQUE, SPECIALIZED COACHING, AND ADEQUATE SAFETY PRECAUTIONS, 2) BROADEN THE DEMONSTRATION PROJECT INTO A LARGER AND SELF-SUSTAINING CLUB FOR THE LOCAL SCI COMMUNITY, AND 3) EXTEND ROWING PERFORMANCE AND EXERCISE INTENSITY BY TRANSLATING LABORATORY-BASED NEURAL STIMULATION TECHNIQUES TO ON-WATER SCULLING (E-SCULLING)
DR. PERI DAVITKOV, MD-NCI "FORTE (FIVE- OR TEN-YEAR COLONOSCOPY FOR 1-2 NON-ADVANCED ADENOMATOUS POLYPS)" THIS STUDY WILL HELP TO DETERMINE IF CERTAIN PEOPLE CAN WAIT FOR A FOLLOW- UP COLONOSCOPY...
DR. PERI DAVITKOV, MD-NCI "FORTE (FIVE- OR TEN-YEAR COLONOSCOPY FOR 1-2 NON-ADVANCED ADENOMATOUS POLYPS)" THIS STUDY WILL HELP TO DETERMINE IF CERTAIN PEOPLE CAN WAIT FOR A FOLLOW- UP COLONOSCOPY AFTER A ROUTINE SCREENING COLONOSCOPY. IT IS A RANDOMIZED CLINICAL TRIAL FOR PEOPLE WHO HAVE ONE OR TWO SMALL, NONCANCEROUS POLYPS (ADENOMAS) REMOVED DURING A ROUTINE SCREENING COLONOSCOPY. SUCH PEOPLE USUALLY GET REPEAT COLONOSCOPIES 5 YEARS AND 10 YEARS LATER (THE CURRENT STANDARD OF CARE FOR PEOPLE WHO HAVE HAD ONE OR TWO BENIGN POLYPS REMOVED). FORTE WILL HELP DETERMINE IF THESE PEOPLE CAN WAIT 10 YEARS BEFORE A FOLLOW-UP TEST. A TOTAL OF 9,500 PEOPLE, AT ALL SITES, WHO HAVE HAD ONE OR TWO BENIGN (NONCANCEROUS) POLYPS REMOVED DURING A ROUTINE SCREENING COLONOSCOPY WILL BE ASSIGNED BY CHANCE TO ONE OF TWO STUDY GROUPS. IN ONE GROUP, PARTICIPANTS WILL HAVE REPEAT COLONOSCOPIES AT BOTH 5 AND 10 YEARS. IN THE OTHER GROUP, PARTICIPANTS WILL HAVE THEIR NEXT COLONOSCOPY EXAM AT 10 YEARS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $5,207,373 | $5,477,583 | 0.0% |
| Expenses | $5,556,320 | $5,711,189 | 0.0% |
| Net Income | $-348,947 | $-233,606 | +0.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JEFF MOORE PHD | EXECUTIVE DI | 40.00 |
Officer
|
$156,434 | $19,044 | $175,478 |
| BRIGID WILSON | HCE | 40.00 |
Highest
|
$128,285 | $40,185 | $168,470 |
| RICHARD DECHANT | TRUSTEE/DIRE | 1.00 |
Director
|
$0 | $0 | $0 |
| ANDREW PACYNA FACHE | PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| GEORGE JASKIW MD | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MURRAY ALTOSE MD | TRUSTEE/DIRE | 1.00 |
Director
|
$0 | $0 | $0 |
| SIMRAN SINGH MD | TRUSTEE/DIRE | 1.00 |
Director
|
$0 | $0 | $0 |
| YNGVE FALCK-YTTER MD | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| NEAL PEACHEY PHD | VICE PRESIDE | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $5,207,373 | $5,556,320 | $3,354,578 | $-348,947 |
| 2024 | No data | No data | No data | No data |
| 2023 | $4,390,885 | $4,832,226 | $3,996,568 | $-441,341 |
| 2022 | $3,836,219 | $5,005,500 | $4,723,141 | $-1,169,281 |
| 2021 | $4,153,737 | $4,489,509 | $5,763,350 | $-335,772 |
| 2020 | $4,518,420 | $4,934,357 | $6,252,832 | $-415,937 |
| 2019 | $4,797,846 | $4,326,402 | $6,300,247 | $471,444 |
| 2018 | $4,945,254 | $3,384,538 | $5,732,904 | $1,560,716 |
Compare CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION with other nonprofits in Ohio and across the country.